Market Access Capping the cost of insulin: altruistic or strategic? The price of insulin has become one of the most talked about issues across the pharma industry.
Market Access The female force behind healthcare innovation Passionate, effective, and forward-thinking female leaders are critical to driving innovation.
Market Access Are we entering a new era of blockbuster weight-loss drugs? Has the industry found a new revenue driver in weight-loss treatments?
Market Access Questions about Humira biosimilars? Widely anticipated biosimilars for Humira are set to enter the US market this year.
Market Access Shifting HCP access calls for new field tactics globally Even before COVID-19 pushed access to an all-time low, access had been declining
Market Access Why we need to support healthcare’s vital acceleration What do I mean by vital acceleration?
News Rezzayo antifungal okayed as Candida auris rings alarm bells Drug is first new echinocandin to be approved for marketing in the US in more than a decade.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
